-
Loading metrics
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model
- Alexander Y. Deneka,
- Leora Haber,
- Meghan C. Kopp,
- Anna V. Gaponova,
- Anna S. Nikonova,
- Erica A. Golemis
x
- Published: April 28, 2017
- https://doi.org/10.1371/journal.pone.0176747